Literature DB >> 23583203

Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90.

Mirela Matokanovic1, Karmela Barisic, Jelena Filipovic-Grcic, Dusica Maysinger.   

Abstract

Inducers of heat shock protein 70 (Hsp70) commonly promote cancer cell viability whereas inhibitors of Hsp90 reduce it. The anticancer agent celastrol, interferes with signal transduction pathways involving these heat shock proteins. The objective of this in vitro study was to silence inducible Hsp70 and to promote celastrol-induced tumor cell death. Hsp70 siRNA loaded chitosan-TPP carriers were prepared by ionic gelation and characterized by photon correlation spectroscopy and asymmetric flow field-flow fractionation combined with dynamic light scattering. Viability of human leukemia and glioblastoma cells and Hsp70 silencing was determined following treatment with chitosan-TPP-Hsp70 siRNA particles. The results showed that silencing of Hsp70 by chitosan-TPP-Hsp70 siRNA treatment significantly reduced cell viability, and enhanced antiproliferative effects of celastrol in leukemia and glioblastoma cells. In glioblastoma spheroids, higher concentrations of celastrol and Hsp70 siRNA in chitosan-TPP nanocarriers were necessary to induce cell death.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Celastrol; Chitosan; HSP; Hsp; Hsp70; RNA interference; RNAi; Tumor spheroids; heat shock protein; heat shock protein family; siRNA; siRNA nanocarriers; small interfering RNA

Mesh:

Substances:

Year:  2013        PMID: 23583203     DOI: 10.1016/j.ejps.2013.04.001

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  14 in total

Review 1.  The human HSP70 family of chaperones: where do we stand?

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

2.  A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS.

Authors:  Marianna Halasi; Renáta Váraljai; Elizaveta Benevolenskaya; Andrei L Gartel
Journal:  J Biol Chem       Date:  2015-11-11       Impact factor: 5.157

3.  Could the Anti-Chaperone VER155008 Replace Temozolomide for Glioma Treatment.

Authors:  Leroy Shervington; Harshada Patil; Amal Shervington
Journal:  J Cancer       Date:  2015-07-04       Impact factor: 4.207

4.  Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.

Authors:  Rebeca Piatniczka Iglesia; Mariana Brandão Prado; Lilian Cruz; Vilma Regina Martins; Tiago Góss Santos; Marilene Hohmuth Lopes
Journal:  Stem Cell Res Ther       Date:  2017-04-17       Impact factor: 6.832

5.  Inhibition of JAK2/STAT3 Signaling Pathway Suppresses Proliferation of Burkitt's Lymphoma Raji Cells via Cell Cycle Progression, Apoptosis, and Oxidative Stress by Modulating HSP70.

Authors:  Neng-Wen Xu; Yu Chen; Wei'e Liu; Yan-Jie Chen; Zhi-Min Fan; Min Liu; Lin-Jie Li
Journal:  Med Sci Monit       Date:  2018-09-08

Review 6.  Low-Temperature Photothermal Therapy: Strategies and Applications.

Authors:  Xiulin Yi; Qiu-Yi Duan; Fu-Gen Wu
Journal:  Research (Wash D C)       Date:  2021-05-07

7.  Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol.

Authors:  Lu Cao; Xue Zhang; Fanfan Cao; Ying Wang; Yufan Shen; Chunxin Yang; Georges Uzan; Bin Peng; Denghai Zhang
Journal:  BMC Cancer       Date:  2015-11-09       Impact factor: 4.430

8.  Peptide deformylase inhibitor actinonin reduces celastrol's HSP70 induction while synergizing proliferation inhibition in tumor cells.

Authors:  Bin Peng; Xue Zhang; Fanfan Cao; Ying Wang; Limin Xu; Lu Cao; Chunxin Yang; Maoquan Li; Georges Uzan; Denghai Zhang
Journal:  BMC Cancer       Date:  2014-03-04       Impact factor: 4.430

9.  Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.

Authors:  Qi-Wei Jiang; Ke-Jun Cheng; Xiao-Long Mei; Jian-Ge Qiu; Wen-Ji Zhang; You-Qiu Xue; Wu-Ming Qin; Yang Yang; Di-Wei Zheng; Yao Chen; Meng-Ning Wei; Xu Zhang; Min Lv; Mei-Wan Chen; Xing Wei; Zhi Shi
Journal:  Oncotarget       Date:  2015-10-20

Review 10.  Stress Response Leading to Resistance in Glioblastoma-The Need for Innovative Radiotherapy (iRT) Concepts.

Authors:  Stephanie E Combs; Thomas E Schmid; Peter Vaupel; Gabriele Multhoff
Journal:  Cancers (Basel)       Date:  2016-01-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.